These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7850674)

  • 1. What do we really know about secondary prevention after myocardial infarction?
    Wielgosz AT
    Can J Cardiol; 1995 Jan; 11 Suppl A():31A-32A. PubMed ID: 7850674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary prevention after myocardial infarction].
    Czuriga I
    Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention for patients following a myocardial infarction: summary of NICE guidance.
    Skinner JS; Cooper A; Feder GS;
    Heart; 2007 Jul; 93(7):862-4. PubMed ID: 17569811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention in elderly survivors of heart attacks.
    Davenport J; Whittaker K
    Am Fam Physician; 1988 Jul; 38(1):216-24. PubMed ID: 2899386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part III. Secondary prevention of ischaemic heart disease after discharge].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):964-8. PubMed ID: 11987836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of pharmacotherapy in secondary prevention of myocardial infarction and death.
    Gorlin R; Fuster V
    Mt Sinai J Med; 1984 Jun; 51(3):229-36. PubMed ID: 6146929
    [No Abstract]   [Full Text] [Related]  

  • 8. [Second prevention following myocardial infarct].
    Burkart F
    Schweiz Med Wochenschr; 1984 Jan; 114(3):104-7. PubMed ID: 6142527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction.
    Skinner JS; Minhas R
    Heart; 2007 Jul; 93(7):864-6. PubMed ID: 17569812
    [No Abstract]   [Full Text] [Related]  

  • 11. [Secondary prevention following myocardial infarct].
    Follath F
    Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1177-80. PubMed ID: 2877482
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of secondary prevention of heart disease in Europe: lifestyle getting worse, therapy getting better in Ireland.
    Hall M; McGettigan M; O'Callaghan P; Graham I; Shelley E; Feely J
    Ir Med J; 2002 Oct; 95(9):272-4. PubMed ID: 12469998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary prevention after myocardial infarction--beta blockade and acetylsalicylic acid is the basic therapy].
    Bergstrand R; Johansson S; Ulvenstam G; Aberg A; Wilhelmsen L
    Lakartidningen; 1989 Jan; 86(1-2):47-50. PubMed ID: 2562999
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW; Madhavan SS; Amonkar MM
    Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of postmyocardial infarction in the elderly patient.
    Forman R; Aronow WS
    Clin Geriatr Med; 1996 Feb; 12(1):169-80. PubMed ID: 8653656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
    Giannuzzi P; Temporelli PL; Marchioli R; Maggioni AP; Balestroni G; Ceci V; Chieffo C; Gattone M; Griffo R; Schweiger C; Tavazzi L; Urbinati S; Valagussa F; Vanuzzo D;
    Arch Intern Med; 2008 Nov; 168(20):2194-204. PubMed ID: 19001195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary prevention after myocardial infarction].
    Vacheron A; Bounhoure JP;
    Bull Acad Natl Med; 2007 Nov; 191(8):1763-77. PubMed ID: 18666472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievement of secondary preventive goals after acute myocardial infarction: a comparison between participants and nonparticipants in a routine patient education program in Sweden.
    Bellman C; Hambraeus K; Lindbäck J; Lindahl B
    J Cardiovasc Nurs; 2009; 24(5):362-8. PubMed ID: 19652617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of secondary myocardial infarction].
    Degeorges M; Boissel JP; Guermonprez JL; Sultan Y; Weber S
    Sem Hop; 1981 Oct 18-25; 57(39-40):1623-5. PubMed ID: 6119791
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of myocardial reinfarction. Recommendations based on results of drug trials.
    Flaker GC; Singh VN
    Postgrad Med; 1993 Nov; 94(6):94-8, 102-4. PubMed ID: 7901845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.